We are excited to be partnering with BC Platforms to bring personalized healthcare solutions into our clinical practice and research. We are looking forward to working with BC Platforms to set a new standard for predictive medicine complementing conventional treatment for our patients and clients across the globe.

We are excited to be collaborating with BC Platforms to securely share our data for the benefit of patients without compromising any privacy issues. We have been impressed by the BCRQUEST.com platform and its ability to analyze, integrate and share data in a secure manner and in line with the European General Data Protection Regulation (GDPR) to support researchers in developing personalized medicines.

BC Platforms is quite unique in some aspects, because as a supplier it operates very much more as a collaborator. And from a platform perspective, very much of the work we are trying to achieve, both in medical research and utilizing new data science technology, and utilizing new techniques in medicine is very complicated and challenging, and so really having a partner, prepared to listen to us and taking critisism from us, is very enabling for us. So BC Platforms as a vendor is more of a partnership.

The HELIOS study will thus provide a powerful resource for medical research across a wide range of disciplines for both the current and future generations of biomedical researchers. We’re delighted to have selected BC Platforms as a key delivery partner in this important healthcare project.